C4 Therapeutics, Inc. (CCCC) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading CCCC…

C4 Therapeutics, Inc. (CCCC) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

C4 Therapeutics, Inc.

CCCC · CIK 1662579

4 · Oct 2, 2026 · Director Anderson Kenneth Carl was granted 3,662 shares at $3.14/share ($11,499)

4

Director Anderson Kenneth Carl was granted 3,662 shares at $3.14/share ($11,499)

Filed: Oct 2, 2026
Period: Oct 1, 2026
Accession: 0001470831-26-000925
Filer: C4 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1790973827.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1790973827.xml
Open SEC.gov